Magnetic resonance spectroscopy reveals abnormalities of glucose metabolism in the Alzheimer's brain

Brain glucose hypometabolism is a prominent feature of Alzheimer's disease (AD), and in this case–control study we used Magnetic Resonance Spectroscopy (MRS) to assess AD‐related differences in the posterior cingulate/precuneal ratio of glucose, lactate, and other metabolites.

• Publication year

  2018

• Venue

  Annals of Clinical and Translational Neurology

• Publication date

  2018-01-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/acn3.530PMID 29560372PMCID 5846391
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin resistance in Alzheimer's disease

  2017cited by this paper
• Alterations in Glucose Metabolism in Alzheimer's Disease.

  2016cited by this paper
• Aerobic Glycolysis in the Frontal Cortex Correlates with Memory Performance in Wild-Type Mice But Not the APP/PS1 Mouse Model of Cerebral Amyloidosis

  2016cited by this paper
• Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder

  2016cited by this paper
• Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease

  2016cited by this paper
• Individual estimates of age at detectable amyloid onset for risk factor assessment

  2016cited by this paper
• Neuroinflammation in Alzheimer's disease.

  2015cited by this paper
• Posterior Cingulate Lactate as a Metabolic Biomarker in Amnestic Mild Cognitive Impairment

  2015cited by this paper
• Insulin in the Brain: Its Pathophysiological Implications for States Related with Central Insulin Resistance, Type 2 Diabetes and Alzheimer’s Disease

  2014cited by this paper
• CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer's disease

  2014cited by this paper
• Early Alzheimer's Disease Neuropathology Detected by Proton MR Spectroscopy

  2014cited by this paper
• Relationship Between Brain Glutamate Levels and Clinical Outcome in Individuals at Ultra High Risk of Psychosis

  2014cited by this paper
• Ascorbic Acid and the Brain: Rationale for the Use against Cognitive Decline

  2014cited by this paper
• Glucose metabolism in normal aging and Alzheimer’s disease: methodological and physiological considerations for PET studies

  2013cited by this paper
• Measuring glucose concentrations in the rat brain using echo‐time‐averaged point resolved spectroscopy at 7 tesla

  2013cited by this paper
• Posteromedial cortex glutamate and GABA predict intrinsic functional connectivity of the default mode network

  2013cited by this paper
• Cerebrospinal Fluid Glucose and Lactate: Age-Specific Reference Values and Implications for Clinical Practice

  2012influential reference
• An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.

  2012cited by this paper
• Amyloid deposition, hypometabolism, and longitudinal cognitive decline

  2012cited by this paper
• Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.

  2012cited by this paper
• The Role of Glucose Transporters in Brain Disease: Diabetes and Alzheimer’s Disease

  2012cited by this paper
• Association of 1H-MR Spectroscopy and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: Diverging Behavior at Three Different Brain Regions

  2012cited by this paper
• Elevated Serum C-Reactive Protein Relates to Increased Cerebral Myoinositol Levels in Middle-Aged Adults

  2012cited by this paper
• Neuronal activity regulates the regional vulnerability to amyloid-β deposition

  2011cited by this paper
• Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial

  2011cited by this paper
• Longitudinal patterns of β-amyloid deposition in nondemented older adults.

  2011cited by this paper
• Brain fuel metabolism, aging, and Alzheimer's disease.

  2011cited by this paper
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• S5‐02‐05: Loss of structural, functional and effective connectivity of the visual system in healthy aging, mild cognitive impairment and Alzheimer's disease

  2010cited by this paper
• Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

  2010cited by this paper
• Brain Ventricular Volume and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease

  2010cited by this paper
• Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition

  2010cited by this paper
• Amyloid deposition is associated with impaired default network function in older persons without dementia.

  2009cited by this paper
• Disruption of Functional Connectivity in Clinically Normal Older Adults Harboring Amyloid Burden

  2009cited by this paper
• CSF biomarker levels in early and late onset Alzheimer's disease.

  2009cited by this paper
• Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.

  2008cited by this paper
• Vitamin C estimation with standard 1H spectroscopy using a clinical 3T MR system: Detectability and reliability within the human brain

  2008cited by this paper
• Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease

  2008cited by this paper
• Quantitation, regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer’s disease

  2007cited by this paper
• Improved two‐dimensional J‐resolved spectroscopy

  2006cited by this paper
• Use of tissue water as a concentration reference for proton spectroscopic imaging

  2006cited by this paper
• Ageing and neuronal vulnerability

  2006cited by this paper
• Effects of Alzheimer Disease on Fronto-parietal Brain N-acetyl Aspartate and Myo-Inositol Using Magnetic Resonance Spectroscopic Imaging

  2006cited by this paper
• ProFit: two‐dimensional prior‐knowledge fitting of J‐resolved spectra

  2006cited by this paper
• Unified segmentation

  2005cited by this paper
• Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

  2005cited by this paper
• Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease

  2005cited by this paper
• Unified segmentation

  2005cited by this paper
• Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD

  2004cited by this paper
• Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake

  2003cited by this paper
• Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET)

  2001cited by this paper
• Ascorbate regulation and its neuroprotective role in the brain.

  2000influential reference
• Alzheimer Disease: Absolute Quantification of Cerebral Metabolites In Vivo Using Localized Proton Magnetic Resonance Spectroscopy

  2000cited by this paper
• A 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression.

  1999cited by this paper
• Astrocytes Couple Synaptic Activity to Glucose Utilization in the Brain.

  1999cited by this paper
• Abnormal Substrate Levels That Depend upon Mitochondrial Function in Cerebrospinal Fluid from Alzheimer Patients

  1998influential reference
• Prediction of cognitive decline in early Alzheimer's disease.

  1998cited by this paper
• Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy.

  1997cited by this paper
• Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

  1996cited by this paper
• Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.

  1995cited by this paper
• Abnormal cerebral metabolite concentrations in patients with probable alzheimer disease

  1994influential reference
• Effects of hyperglycemia on FDG uptake in human brain and glioma.

  1994cited by this paper
• Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease

  1994cited by this paper
• Estimation of metabolite concentrations from localized in vivo proton NMR spectra

  1993cited by this paper
• Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra.

  1993cited by this paper
• Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy.

  1992cited by this paper
• Vitamin C: Its Chemistry and Biochemistry

  1991cited by this paper
• Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268

  1990cited by this paper
• STUDIES OF THE INTER‐RELATIONSHIP BETWEEN CEREBROSPINAL FLUID AND PLASMA AMINO ACID CONCENTRATIONS IN NORMAL INDIVIDUALS

  1977cited by this paper

• Energy metabolism in health and diseases

  2025cites this paper
• Type 3 diabetes and metabolic reprogramming of brain neurons: causes and therapeutic strategies

  2025cites this paper
• Metabolic Profiling of Brain Tissue and Brain‐Derived Extracellular Vesicles in Alzheimer's Disease

  2025cites this paper
• Lactate and lactylation in intervertebral disc degeneration

  2025cites this paper
• 1H-MR spectroscopy biomarkers are associated with plasma-derived biomarkers of amyloid-β and tau in the early phase of AD continuum.

  2025cites this paper
• Stimulated Raman Scattering Imaging Enabled Biomarker Discovery for Precision Medicine

  2025cites this paper
• Glucose Metabolism, Lactate, Lactylation and Alzheimer's Disease.

  2025cites this paper
• Normal cerebral oxygen consumption and lactate levels in patients with Alzheimer's disease and Lewy body dementia.

  2025cites this paper
• Large-scale animal model study uncovers altered brain pH and lactate levels as a transdiagnostic endophenotype of neuropsychiatric disorders involving cognitive impairment

  2024cites this paper
• A Magnetic Resonance Spectroscopy Study on Polarity Subphenotypes in Bipolar Disorder

  2024cites this paper
• Applications of magnetic resonance spectroscopy in diagnosis of neurodegenerative diseases: A systematic review

  2024influential citation
• Decreased Brain pH Correlated With Progression of Alzheimer Disease Neuropathology: A Systematic Review and Meta-Analyses of Postmortem Studies

  2024cites this paper
• Magnetic Resonance Spectroscopy (MRS) in Alzheimer's Disease.

  2024cites this paper
• Icariin ameliorates glycolytic dysfunction in Alzheimer's disease models by activating the Wnt/β‐catenin signaling pathway

  2024cites this paper
• Brain insulin resistance and Alzheimer’s disease: a systematic review

  2024cites this paper
• 3D convolutional neural networks uncover modality-specific brain-imaging predictors for Alzheimer’s disease sub-scores

  2024cites this paper
• Altered metabolism and DAM-signatures in female brains and microglia with aging.

  2024cites this paper
• Lactic acid promotes nucleus pulposus cell senescence and corresponding intervertebral disc degeneration via interacting with Akt

  2024cites this paper
• Intestinal endogenous metabolites affect neuroinflammation in 5×FAD mice by mediating “gut-brain” axis and the intervention with Chinese Medicine

  2024cites this paper
• Understanding Proton Magnetic Resonance Spectroscopy Neurochemical Changes Using Alzheimer’s Disease Biofluid, PET, Postmortem Pathology Biomarkers, and APOE Genotype

  2024cites this paper
• Honokiol relieves hippocampal neuronal damage in Alzheimer's disease by activating the SIRT3‐mediated mitochondrial autophagy

  2024cites this paper
• Brain responses to intermittent fasting and the healthy living diet in older adults.

  2024cites this paper
• Multimodal investigation of neuropathology and neurometabolites in mild cognitive impairment and late-life depression with 11C-PiB beta-amyloid PET and 7T magnetic resonance spectroscopy.

  2024cites this paper
• Feasibility of Using Magnetic Resonance Spectroscopy Test Biomarkers to Diagnose Alzheimer's Disease: Systematic Evaluation and Meta-Analysis

  2024cites this paper
• Correlation between abnormal cellular immune and changes of magnetic resonance spectroscopy in patients with Alzheimer's disease.

  2024cites this paper
• Does hyperphenylalaninemia induce brain glucose hypometabolism? Cerebral spinal fluid findings in treated adult phenylketonuric patients.

  2024cites this paper
• Altered Brain Energy Metabolism Related to Astrocytes in Alzheimer's Disease

  2023influential citation
• Functional Magnetic Resonance Spectroscopy of Lactate in Alzheimer Disease: A Comprehensive Review of Alzheimer Disease Pathology and the Role of Lactate

  2023cites this paper
• Systemic Metabolism and Mitochondria in the Mechanism of Alzheimer’s Disease: Finding Potential Therapeutic Targets

  2023cites this paper
• The Cleavage-Specific Tau 12A12mAb Exerts an Anti-Amyloidogenic Action by Modulating the Endocytic and Bioenergetic Pathways in Alzheimer’s Disease Mouse Model

  2023cites this paper
• Integrative metabolomics science in Alzheimer's disease: relevance and future perspectives.

  2023cites this paper
• Metabolomic profiling of CSF and blood serum elucidates general and sex-specific patterns for mild cognitive impairment and Alzheimer’s disease patients

  2023cites this paper
• Randomized placebo‐controlled crossover study to assess tolerability and pharmacodynamics of zagociguat, a soluble guanylyl cyclase stimulator, in healthy elderly

  2023cites this paper
• Operational Modal Analysis of Near-Infrared Spectroscopy Measure of 2-Month Exercise Intervention Effects in Sedentary Older Adults with Diabetes and Cognitive Impairment

  2023cites this paper
• Mass spectrometry in cerebrospinal fluid uncovers association of glycolysis biomarkers with Alzheimer’s disease in a large clinical sample

  2023cites this paper
• Altered Metabolism and DAM-signatures in Female Brains and Microglia with Aging

  2023cites this paper
• In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy

  2023cites this paper
• Acute administration of ketone beta-hydroxybutyrate downregulates 7T proton magnetic resonance spectroscopy-derived levels of anterior and posterior cingulate GABA and glutamate in healthy adults

  2022cites this paper
• 1H MR spectroscopy biomarkers of neuronal and synaptic function are associated with tau deposition in cognitively unimpaired older adults.

  2022cites this paper
• Ketone Ester Effects on Biomarkers of Brain Metabolism and Cognitive Performance in Cognitively Intact Adults ≥ 55 Years Old. A Study Protocol for a Double-Blinded Randomized Controlled Clinical Trial

  2022cites this paper
• Metabolic Features of Brain Function with Relevance to Clinical Features of Alzheimer and Parkinson Diseases

  2022cites this paper
• nEffects of ketogenic diet on cognitive functions of mice fed high-fat-high-cholesterol diet.

  2022cites this paper
• Characterizing brain imaging features associated with ADAS-Cog13 sub-scores with 3D convolutional neural networks

  2022cites this paper
• Brain Metabolic Alterations in Alzheimer’s Disease

  2022cites this paper
• Glucose Metabolism, Neural Cell Senescence and Alzheimer’s Disease

  2022cites this paper
• Transcriptomic analysis to elucidate the response of Apis mellifera ligustica brain tissue to fluvalinate exposure

  2022cites this paper
• Exogenous Ketones and Lactate as a Potential Therapeutic Intervention for Brain Injury and Neurodegenerative Conditions

  2022cites this paper
• Lactate Is Answerable for Brain Function and Treating Brain Diseases: Energy Substrates and Signal Molecule

  2022cites this paper
• High-resolution NMR metabolomics of patients with subjective cognitive decline plus: Perturbations in the metabolism of glucose and branched-chain amino acids.

  2022cites this paper
• Upregulation of ribosome complexes at the blood-brain barrier in Alzheimer's disease patients

  2022cites this paper
• Longitudinal evaluation of proton magnetic resonance spectroscopy metabolites as biomarkers in Huntington’s disease

  2022cites this paper
• Empagliflozin Induced Ketosis, Upregulated IGF-1/Insulin Receptors and the Canonical Insulin Signaling Pathway in Neurons, and Decreased the Excitatory Neurotransmitter Glutamate in the Brain of Non-Diabetics

  2022cites this paper
• Coordinated Regulation of Myelination by Growth Factor and Amino-acid Signaling Pathways

  2022cites this paper
• Cerebrospinal fluid glucose is not altered in patients with dementia.

  2022cites this paper
• Mitochondrial Dysfunction in Alzheimer’s Disease: A Biomarker of the Future?

  2021cites this paper
• Disentangling Mitochondria in Alzheimer’s Disease

  2021cites this paper
• Longitudinal Evaluation of Magnetic Resonance Spectroscopy Metabolites as Biomarkers in Huntington’s Disease Running Title: MRS Metabolites in Huntington’s Disease

  2021cites this paper
• (2021). Widespread severe cerebral elevations of haptoglobin and haemopexin in sporadic Alzheimer's disease: Evidence for a pervasive microvasculopathy. Biochemical and Biophysical Research

  2021cites this paper
• Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies.

  2021cites this paper
• Brain energy failure in dementia syndromes: Opportunities and challenges for glucagon‐like peptide‐1 receptor agonists

  2021cites this paper
• Ketones: potential to achieve brain energy rescue and sustain cognitive health during ageing

  2021cites this paper
• Altered central and blood glutathione in Alzheimer’s disease and mild cognitive impairment: a meta-analysis

  2021influential citation
• Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease

  2021cites this paper
• Ketogenic diet therapy in Alzheimer's disease: an updated review

  2021cites this paper
• Widespread severe cerebral elevations of haptoglobin and haemopexin in sporadic Alzheimer's disease: Evidence for a pervasive microvasculopathy.

  2021cites this paper
• Reduced Cerebral Glucose Uptake in an Alzheimer’s Rat Model With Glucose-Weighted Chemical Exchange Saturation Transfer Imaging

  2021cites this paper
• Large-scale animal model study uncovers altered brain pH and lactate levels as a transdiagnostic endophenotype of neuropsychiatric disorders involving cognitive impairment

  2021cites this paper
• The effects of metformin on high-fat diet-induced neuroinflammation and cognitive impairment

  2020cites this paper
• Glucose metabolism: A link between traumatic brain injury and Alzheimer’s disease

  2020cites this paper
• CSF glucose tracks regional tau progression based on Alzheimer's disease risk factors

  2020cites this paper
• Brain glucose and ketone utilization in brain aging and neurodegenerative diseases.

  2020cites this paper
• Cerebrospinal Fluid Amyloid Beta, Tau Levels, Apolipoprotein, and 1H-MRS Brain Metabolites in Alzheimer's Disease: A Systematic Review.

  2020cites this paper
• GABAergic dysfunction in excitatory and inhibitory (E/I) imbalance drives the pathogenesis of Alzheimer's disease

  2020cites this paper
• Lactate dehydrogenase expression modulates longevity and neurodegeneration in Drosophila melanogaster

  2020cites this paper
• Cerebral deficiency of vitamin B5 (d-pantothenic acid; pantothenate) as a potentially-reversible cause of neurodegeneration and dementia in sporadic Alzheimer's disease.

  2020cites this paper
• Distinctive Neurochemistry in Alzheimer’s Disease via 7 T In Vivo Magnetic Resonance Spectroscopy

  2019cites this paper
• “Alzheimer's disease” is neither “Alzheimer's clinical syndrome” nor “dementia”

  2019cites this paper
• Medium Chain Triglycerides induce mild ketosis and may improve cognition in Alzheimer's disease. A systematic review and meta-analysis of human studies.

  2019cites this paper
• Functional MRI of brain physiology in aging and neurodegenerative diseases

  2019cites this paper
• A pilot study of exenatide actions in Alzheimer's disease.

  2019cites this paper
• Metabolite Profile of Alzheimer’s Disease in the Frontal Cortex as Analyzed by HRMAS 1H NMR

  2019cites this paper
• Dietary Neuroketotherapeutics for Alzheimer’s Disease: An Evidence Update and the Potential Role for Diet Quality

  2019cites this paper
• Analysis of Whole-Exome Sequencing Data for Alzheimer Disease Stratified by APOE Genotype.

  2019cites this paper
• Canine Cognitive Dysfunction: Pathophysiology, Diagnosis, and Treatment.

  2019cites this paper
• Brain insulin resistance and altered brain glucose are related to memory impairments in schizophrenia.

  2019cites this paper
• Metabolomic Assays of Postmortem Brain Extracts: Pitfalls in Extrapolation of Concentrations of Glucose and Amino Acids to Metabolic Dysregulation In Vivo in Neurological Diseases

  2018cites this paper
• MAGNETIC RESONANCE SPECTROSCOPY ( MRS ) Guideline

  2018cites this paper
• Statistica Sinica Preprint No: SS-2023-0071

  year unknowncites this paper
• The effects of metformin on high-fat diet-induced The effects of metformin on high-fat diet-induced neuroinflammation and cognitive impairment neuroinflammation and cognitive impairment

  year unknowncites this paper